Login / Signup

The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer.

Xiuli TaoNing LiNing WuJie HeJianming YingShugeng GaoShuhang WangJie WangZhijie WangYun LingWei TangZewei Zhang
Published in: European journal of nuclear medicine and molecular imaging (2020)
18F-FDG PET-CT can predict MPR to neoadjuvant sintilimab in resectable non-small cell lung cancer.
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy